Results 151 to 160 of about 419,456 (202)
Some of the next articles are maybe not open access.
Addressing the Inactivated Poliovirus Vaccine Shortage
Lancet, The, 2019Roland W, Sutter, Michel, Zaffran
exaly +3 more sources
Seventy eight infants aged 6-8 weeks received either two doses of 0.1 ml of inactivated poliovirus vaccine (IPV) intradermally 8 weeks apart (group A) or three doses 4 weeks apart (group B).
T Jacob John +2 more
exaly +2 more sources
Clinical Diagnostic Laboratory Immunology, 1997
In The Netherlands the inactivated poliovirus vaccine (IPV) is used for protection against poliomyelitis. It is not clear if parenteral vaccination with IPV can lead to priming of the mucosal immune system. We developed and evaluated enzyme-linked immunosorbent assays for the detection of poliovirus serotype-specific immunoglobulin A (IgA) and ...
Herremans, MMPT +6 more
openaire +4 more sources
In The Netherlands the inactivated poliovirus vaccine (IPV) is used for protection against poliomyelitis. It is not clear if parenteral vaccination with IPV can lead to priming of the mucosal immune system. We developed and evaluated enzyme-linked immunosorbent assays for the detection of poliovirus serotype-specific immunoglobulin A (IgA) and ...
Herremans, MMPT +6 more
openaire +4 more sources
Efficacy and safety of oral poliovirus vaccine and inactivated poliovirus vaccine
Pediatric Infectious Disease, 1991Inactivated poliovirus vaccine (IPV) is the vaccine of choice for protection against paralytic poliomyelitis provided that it is used within the context of a program to increase and sustain the level of uptake to as close to 100% as possible. This means targeting the disadvantaged in society as well as those who have their own pediatrician. The reasons
openaire +2 more sources
Change From Oral Poliovirus Vaccine to Inactivated Poliovirus Vaccine
Lancet, The, 2002Elisabetta Franco +2 more
exaly +2 more sources
Inactivated Poliovirus Vaccine: Past and Present Experience
Vaccine, 1996Many countries have made use of inactivated poliovirus vaccine (IPV) in their national poliovirus control programs since 1955. Until 1961 IPV was the only vaccine available for the control of poliovirus, but subsequently many countries opted to use the Sabin attenuated poliovirus vaccine (OPV), which was perceived as more effective in preventing ...
Luis Barreto, S Plotkin
exaly +3 more sources
Comparison of Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine Programs in Israel
Clinical Infectious Diseases, 1984In spite of high vaccination coverage, paralytic poliomyelitis still occurs in Israel, either in sporadic form in the urban area or in small outbreaks in the rural, non-Jewish segment. At high risk are mainly very young infants, not yet protected by poliovirus vaccine and children who have failed to seroconvert after a full course of oral poliovirus ...
T A, Swartz +4 more
openaire +2 more sources
Fractional Doses of Inactivated Poliovirus Vaccine in Oman
New England Journal of Medicine, 2010We conducted a clinical trial of fractional doses of inactivated poliovirus vaccine administered to infants in Oman, in order to evaluate strategies for making the vaccine affordable for use in developing countries.We compared fractional doses of inactivated poliovirus vaccine (0.1 ml, representing one fifth of a full dose) given intradermally with the
Mohammed, AJ +12 more
openaire +3 more sources
Use of inactivated poliovirus vaccine for poliovirus outbreak response
The Lancet Infectious DiseasesWith continued wild poliovirus transmission in Afghanistan and Pakistan and circulating vaccine-derived poliovirus in certain countries, there exists an ongoing risk of importation of polioviruses into other countries, including those that have been polio-free for decades.
Ananda S, Bandyopadhyay +7 more
openaire +2 more sources
Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman
Journal of Infectious Diseases, 1997Seroprevalence and geometric mean titers (GMTs) were compared at 6 and 10 months after vaccination with monovalent type 1 oral poliovirus vaccine (OPV) at 6 months and trivalent OPV at 7 and 9 months. Group 1 had received 4 doses of OPV, group 2 OPV at birth and 3 doses of OPV and inactivated poliovirus vaccine (IPV), and group 3 placebo at birth and 3
R W, Sutter +9 more
openaire +2 more sources

